Cabenuva
- Product NDC
- 49702-253
- 11-digit product format
- 497020253
- Labeler code
- 49702
- Product ID
- 49702-253_15253b2a-c96c-489c-be6d-b37fcb63ad5b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- cabotegravir and rilpivirine
- Dosage form
- KIT
- Labeler
- ViiV Healthcare Company
- Application
- NDA212888
- Marketing category
- NDA
- Marketing start
- 2021-01-21
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N212888-001 | CABENUVA KIT | CABOTEGRAVIR; RILPIVIRINE | 400MG/2ML (200MG/ML);600MG/2ML (300MG/ML) | SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | RLD | 2021-01-21 | |
| N212888-002 | CABENUVA KIT | CABOTEGRAVIR; RILPIVIRINE | 600MG/3ML (200MG/ML);900MG/3ML (300MG/ML) | SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | RLD, RS | 2021-01-21 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N212888-001 | 10927129 | 2026-04-28 | Drug substance, Drug product | 2021-03-22 | |
| N212888-001 | 11389447 | 2027-06-30 | U-3405 | 2022-08-17 | |
| N212888-001 | 8410103 | 2031-02-04 | U-3348 | Drug substance, Drug product | 2021-02-16 |
| N212888-001 | 11224597 | 2031-09-15 | U-3348 | Drug product | 2022-02-15 |
| N212888-001 | 12138264 | 2031-09-15 | U-3348 | Drug product | 2024-12-05 |
| N212888-001 | RE50189 | 2031-11-27 | U-3348 | 2024-12-16 | |
| N212888-001 | 11389448 | 2032-04-13 | Drug product | 2025-04-30 | |
| N212888-001 | 12178815 | 2038-07-18 | U-3348 | 2025-01-13 | |
| N212888-001 | 12636285 | 2040-10-01 | U-3348 | 2026-06-10 | |
| N212888-001 | 12636286 | 2040-10-01 | U-3348 | 2026-06-10 | |
| N212888-002 | 10927129 | 2026-04-28 | Drug substance, Drug product | 2021-03-22 | |
| N212888-002 | 11389447 | 2027-06-30 | U-3405 | 2022-08-17 | |
| N212888-002 | 8410103 | 2031-02-04 | U-3348 | Drug substance, Drug product | 2021-02-16 |
| N212888-002 | 11224597 | 2031-09-15 | U-3348 | Drug product | 2022-02-15 |
| N212888-002 | 12138264 | 2031-09-15 | U-3348 | Drug product | 2024-12-05 |
| N212888-002 | RE50189 | 2031-11-27 | U-3348 | 2024-12-16 | |
| N212888-002 | 11389448 | 2032-04-13 | Drug product | 2025-04-30 | |
| N212888-002 | 12178815 | 2038-07-18 | U-3348 | 2025-01-13 | |
| N212888-002 | 12636285 | 2040-10-01 | U-3348 | 2026-06-10 | |
| N212888-002 | 12636286 | 2040-10-01 | U-3348 | 2026-06-10 |
Orange Book exclusivity#
| Application-product | Exclusivity code | Expiration |
|---|---|---|
| N212888-001 | NCE | 2026-01-21 |
| N212888-002 | NCE | 2026-01-21 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N212888-001 | CABENUVA KIT | 400MG/2ML (200MG/ML);600MG/2ML (300MG/ML) | SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | RLD, RS | 2021-01-21 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212888-002 | CABENUVA KIT | 600MG/3ML (200MG/ML);900MG/3ML (300MG/ML) | SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | RLD, RS | 2021-01-21 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212888-001 | CABENUVA KIT | 400MG/2ML (200MG/ML);600MG/2ML (300MG/ML) | SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | RLD, RS | 2021-01-21 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212888-002 | CABENUVA KIT | 600MG/3ML (200MG/ML);900MG/3ML (300MG/ML) | SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | RLD, RS | 2021-01-21 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N212888-001 | CABENUVA KIT | 400MG/2ML (200MG/ML);600MG/2ML (300MG/ML) | SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | RLD, RS | 2021-01-21 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N212888-002 | CABENUVA KIT | 600MG/3ML (200MG/ML);900MG/3ML (300MG/ML) | SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | RLD, RS | 2021-01-21 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N212888-001 | CABENUVA KIT | 400MG/2ML (200MG/ML);600MG/2ML (300MG/ML) | SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | RLD, RS | 2021-01-21 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N212888-002 | CABENUVA KIT | 600MG/3ML (200MG/ML);900MG/3ML (300MG/ML) | SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | RLD, RS | 2021-01-21 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N212888-001 | CABENUVA KIT | 400MG/2ML (200MG/ML);600MG/2ML (300MG/ML) | SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | RLD, RS | 2021-01-21 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N212888-002 | CABENUVA KIT | 600MG/3ML (200MG/ML);900MG/3ML (300MG/ML) | SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | RLD, RS | 2021-01-21 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N212888-001 | CABENUVA KIT | 400MG/2ML (200MG/ML);600MG/2ML (300MG/ML) | SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | RLD, RS | 2021-01-21 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N212888-002 | CABENUVA KIT | 600MG/3ML (200MG/ML);900MG/3ML (300MG/ML) | SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | RLD, RS | 2021-01-21 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N212888-001 | CABENUVA KIT | 400MG/2ML (200MG/ML);600MG/2ML (300MG/ML) | SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | RLD, RS | 2021-01-21 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N212888-002 | CABENUVA KIT | 600MG/3ML (200MG/ML);900MG/3ML (300MG/ML) | SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | RLD, RS | 2021-01-21 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N212888-001 | CABENUVA KIT | 400MG/2ML (200MG/ML);600MG/2ML (300MG/ML) | SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | RLD, RS | 2021-01-21 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N212888-002 | CABENUVA KIT | 600MG/3ML (200MG/ML);900MG/3ML (300MG/ML) | SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | RLD, RS | 2021-01-21 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N212888-001 | CABENUVA KIT | 400MG/2ML (200MG/ML);600MG/2ML (300MG/ML) | SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | RLD, RS | 2021-01-21 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N212888-002 | CABENUVA KIT | 600MG/3ML (200MG/ML);900MG/3ML (300MG/ML) | SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | RLD, RS | 2021-01-21 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N212888-001 | CABENUVA KIT | 400MG/2ML (200MG/ML);600MG/2ML (300MG/ML) | SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | RLD, RS | 2021-01-21 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N212888-002 | CABENUVA KIT | 600MG/3ML (200MG/ML);900MG/3ML (300MG/ML) | SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | RLD, RS | 2021-01-21 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N212888-001 | CABENUVA KIT | 400MG/2ML (200MG/ML);600MG/2ML (300MG/ML) | SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | RLD, RS | 2021-01-21 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N212888-002 | CABENUVA KIT | 600MG/3ML (200MG/ML);900MG/3ML (300MG/ML) | SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | RLD, RS | 2021-01-21 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N212888-001 | CABENUVA KIT | 400MG/2ML (200MG/ML);600MG/2ML (300MG/ML) | SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | RLD, RS | 2021-01-21 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N212888-002 | CABENUVA KIT | 600MG/3ML (200MG/ML);900MG/3ML (300MG/ML) | SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | RLD, RS | 2021-01-21 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N212888-001 | CABENUVA KIT | 400MG/2ML (200MG/ML);600MG/2ML (300MG/ML) | SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | RLD, RS | 2021-01-21 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N212888-002 | CABENUVA KIT | 600MG/3ML (200MG/ML);900MG/3ML (300MG/ML) | SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | RLD, RS | 2021-01-21 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N212888-001 | CABENUVA KIT | 400MG/2ML (200MG/ML);600MG/2ML (300MG/ML) | SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | RLD, RS | 2021-01-21 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N212888-002 | CABENUVA KIT | 600MG/3ML (200MG/ML);900MG/3ML (300MG/ML) | SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | RLD, RS | 2021-01-21 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N212888-001 | CABENUVA KIT | 400MG/2ML (200MG/ML);600MG/2ML (300MG/ML) | SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | RLD, RS | 2021-01-21 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N212888-002 | CABENUVA KIT | 600MG/3ML (200MG/ML);900MG/3ML (300MG/ML) | SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | RLD, RS | 2021-01-21 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N212888-001 | CABENUVA KIT | 400MG/2ML (200MG/ML);600MG/2ML (300MG/ML) | SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | RLD, RS | 2021-01-21 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N212888-002 | CABENUVA KIT | 600MG/3ML (200MG/ML);900MG/3ML (300MG/ML) | SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | RLD, RS | 2021-01-21 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N212888-001 | CABENUVA KIT | 400MG/2ML (200MG/ML);600MG/2ML (300MG/ML) | SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | RLD, RS | 2021-01-21 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N212888-002 | CABENUVA KIT | 600MG/3ML (200MG/ML);900MG/3ML (300MG/ML) | SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | RLD, RS | 2021-01-21 | 4b0b4de00fa7… | |
| 2022-03-09 01:35 UTC | 2022-03 | N212888-001 | CABENUVA KIT | 400MG/2ML (200MG/ML);600MG/2ML (300MG/ML) | SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | RLD, RS | 2021-01-21 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | N212888-002 | CABENUVA KIT | 600MG/3ML (200MG/ML);900MG/3ML (300MG/ML) | SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | RLD, RS | 2021-01-21 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N212888-001 | CABENUVA KIT | 400MG/2ML (200MG/ML);600MG/2ML (300MG/ML) | SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | RLD, RS | 2021-01-21 | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N212888-002 | CABENUVA KIT | 600MG/3ML (200MG/ML);900MG/3ML (300MG/ML) | SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | RLD, RS | 2021-01-21 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N212888-001 | CABENUVA KIT | 400MG/2ML (200MG/ML);600MG/2ML (300MG/ML) | SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | RLD, RS | 2021-01-21 | 87673890dc5c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N212888-002 | CABENUVA KIT | 600MG/3ML (200MG/ML);900MG/3ML (300MG/ML) | SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | RLD, RS | 2021-01-21 | 87673890dc5c… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N212888-001 | 10927129 | 2026-04-28 | Drug substance, Drug product | 2021-03-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212888-001 | 11389447 | 2027-06-30 | U-3405 | 2022-08-17 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212888-001 | 8410103 | 2031-02-04 | U-3348 | Drug substance, Drug product | 2021-02-16 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N212888-001 | 11224597 | 2031-09-15 | U-3348 | Drug product | 2022-02-15 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N212888-001 | 12138264 | 2031-09-15 | U-3348 | Drug product | 2024-12-05 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N212888-001 | RE50189 | 2031-11-27 | U-3348 | 2024-12-16 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212888-001 | 11389448 | 2032-04-13 | Drug product | 2025-04-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212888-001 | 12178815 | 2038-07-18 | U-3348 | 2025-01-13 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212888-002 | 10927129 | 2026-04-28 | Drug substance, Drug product | 2021-03-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212888-002 | 11389447 | 2027-06-30 | U-3405 | 2022-08-17 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212888-002 | 8410103 | 2031-02-04 | U-3348 | Drug substance, Drug product | 2021-02-16 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N212888-002 | 11224597 | 2031-09-15 | U-3348 | Drug product | 2022-02-15 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N212888-002 | 12138264 | 2031-09-15 | U-3348 | Drug product | 2024-12-05 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N212888-002 | RE50189 | 2031-11-27 | U-3348 | 2024-12-16 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212888-002 | 11389448 | 2032-04-13 | Drug product | 2025-04-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212888-002 | 12178815 | 2038-07-18 | U-3348 | 2025-01-13 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212888-001 | 7125879 | 2025-04-21 | U-3348 | Drug substance, Drug product | 2021-02-16 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212888-001 | 10927129 | 2026-04-28 | Drug substance, Drug product | 2021-03-22 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212888-001 | 11389447 | 2027-06-30 | U-3405 | 2022-08-17 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212888-001 | 8410103 | 2031-02-04 | U-3348 | Drug substance, Drug product | 2021-02-16 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212888-001 | 11224597 | 2031-09-15 | U-3348 | Drug product | 2022-02-15 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212888-001 | 12138264 | 2031-09-15 | U-3348 | Drug product | 2024-12-05 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212888-001 | RE50189 | 2031-11-27 | U-3348 | 2024-12-16 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212888-001 | 11389448 | 2032-04-13 | Drug product | 2025-04-30 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212888-001 | 12178815 | 2038-07-18 | U-3348 | 2025-01-13 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212888-002 | 7125879 | 2025-04-21 | U-3348 | Drug substance, Drug product | 2021-02-16 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212888-002 | 10927129 | 2026-04-28 | Drug substance, Drug product | 2021-03-22 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212888-002 | 11389447 | 2027-06-30 | U-3405 | 2022-08-17 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212888-002 | 8410103 | 2031-02-04 | U-3348 | Drug substance, Drug product | 2021-02-16 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212888-002 | 11224597 | 2031-09-15 | U-3348 | Drug product | 2022-02-15 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212888-002 | 12138264 | 2031-09-15 | U-3348 | Drug product | 2024-12-05 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212888-002 | RE50189 | 2031-11-27 | U-3348 | 2024-12-16 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212888-002 | 11389448 | 2032-04-13 | Drug product | 2025-04-30 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212888-002 | 12178815 | 2038-07-18 | U-3348 | 2025-01-13 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N212888-001 | 7125879 | 2025-04-21 | U-3348 | Drug substance, Drug product | 2021-02-16 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N212888-001 | 10927129 | 2026-04-28 | Drug substance, Drug product | 2021-03-22 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N212888-001 | 8410103 | 2026-04-28 | U-3348 | Drug substance, Drug product | 2021-02-16 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N212888-001 | 11389447 | 2027-06-30 | U-3405 | 2022-08-17 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N212888-001 | 11224597 | 2031-09-15 | U-3348 | Drug product | 2022-02-15 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N212888-001 | 12138264 | 2031-09-15 | U-3348 | Drug product | 2024-12-05 | 6a471c1ec25d… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N212888-001 | NCE | 2026-01-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N212888-002 | NCE | 2026-01-21 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212888-001 | D-184 | 2025-01-31 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212888-001 | NPP | 2025-03-29 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212888-001 | NCE | 2026-01-21 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212888-002 | D-184 | 2025-01-31 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212888-002 | NPP | 2025-03-29 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212888-002 | NCE | 2026-01-21 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N212888-001 | D-184 | 2025-01-31 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N212888-001 | NPP | 2025-03-29 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N212888-001 | NCE | 2026-01-21 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N212888-002 | D-184 | 2025-01-31 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N212888-002 | NPP | 2025-03-29 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N212888-002 | NCE | 2026-01-21 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N212888-001 | D-184 | 2025-01-31 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N212888-001 | NPP | 2025-03-29 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N212888-001 | NCE | 2026-01-21 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N212888-002 | D-184 | 2025-01-31 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N212888-002 | NPP | 2025-03-29 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N212888-002 | NCE | 2026-01-21 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N212888-001 | D-184 | 2025-01-31 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N212888-001 | NPP | 2025-03-29 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N212888-001 | NCE | 2026-01-21 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N212888-002 | D-184 | 2025-01-31 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N212888-002 | NPP | 2025-03-29 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N212888-002 | NCE | 2026-01-21 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N212888-001 | D-184 | 2025-01-31 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N212888-001 | NPP | 2025-03-29 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N212888-001 | NCE | 2026-01-21 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N212888-002 | D-184 | 2025-01-31 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N212888-002 | NPP | 2025-03-29 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N212888-002 | NCE | 2026-01-21 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N212888-001 | D-184 | 2025-01-31 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N212888-001 | NPP | 2025-03-29 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N212888-001 | NCE | 2026-01-21 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N212888-002 | D-184 | 2025-01-31 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N212888-002 | NPP | 2025-03-29 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N212888-002 | NCE | 2026-01-21 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N212888-001 | D-184 | 2025-01-31 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N212888-001 | NPP | 2025-03-29 | 5bbf6a4d5a75… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Cabenuva
- Listing expiration
- 2026-12-31
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 2475415 | Internal RxNorm lookup |
| 2475416 | Internal RxNorm lookup |
| 2475417 | Internal RxNorm lookup |
| 2475418 | Internal RxNorm lookup |
| 2588077 | Internal RxNorm lookup |
| 2594978 | Internal RxNorm lookup |
| 2594980 | Internal RxNorm lookup |
| 2594982 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1698baf3-f895-4c42-a1b1-e9ee3f20da36 | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 49702-245-01 | Cabenuva | 2 mL in 1 VIAL | INJECTION, SUSPENSION, EXTENDED | 1 mL | 200 mg in 1mL | 16 |
| 49702-249-02 | Cabenuva | 2 mL in 1 VIAL | INJECTION, SUSPENSION, EXTENDED | 1 mL | 300 mg in 1mL | 16 |
| 49702-253-15 | Cabenuva | 1 in 1 CARTON | KIT | 1 | 16 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 49702-253-15 | ML - Milliliter | 49702-253 | 3105582b-c1c7-4f8a-8030-49abb2b1305e | 1 | 2021-02-05 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cabenuva | CABOTEGRAVIR AND RILPIVIRINE | ViiV Healthcare Company | 1698baf3-f895-4c42-a1b1-e9ee3f20da36 | 2025-11-26 | Warnings, Adverse reactions | 212888 NDA212888 49702-253 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 2475418 | {1 (2 ML cabotegravir 200 MG/ML Injection) / 1 (2 ML rilpivirine 300 MG/ML Injection) } Pack [CABENUVA 400 MG / 600 MG] | BPCK | 1698baf3-f895-4c42-a1b1-e9ee3f20da36 | 16 |
| 2475416 | {1 (3 ML cabotegravir 200 MG/ML Injection) / 1 (3 ML rilpivirine 300 MG/ML Injection) } Pack [CABENUVA 600 MG / 900 MG] | BPCK | 1698baf3-f895-4c42-a1b1-e9ee3f20da36 | 16 |
| 2475417 | {1 (2 ML cabotegravir 200 MG/ML Injection) / 1 (2 ML rilpivirine 300 MG/ML Injection) } Pack | GPCK | 1698baf3-f895-4c42-a1b1-e9ee3f20da36 | 16 |
| 2475415 | {1 (3 ML cabotegravir 200 MG/ML Injection) / 1 (3 ML rilpivirine 300 MG/ML Injection) } Pack | GPCK | 1698baf3-f895-4c42-a1b1-e9ee3f20da36 | 16 |
| 2475418 | CABENUVA 400 MG / 600 MG Extended Release Kit | PSN | 1698baf3-f895-4c42-a1b1-e9ee3f20da36 | 16 |
| 2475416 | CABENUVA 600 MG / 900 MG Extended Release Kit | PSN | 1698baf3-f895-4c42-a1b1-e9ee3f20da36 | 16 |
| 2475417 | cabotegravir 400 MG / rilpivirine 600 MG Extended Release Kit | PSN | 1698baf3-f895-4c42-a1b1-e9ee3f20da36 | 16 |
| 2594978 | cabotegravir 400 MG in 2 ML Extended Release Injection | PSN | 1698baf3-f895-4c42-a1b1-e9ee3f20da36 | 16 |
| 2475415 | cabotegravir 600 MG / rilpivirine 900 MG Extended Release Kit | PSN | 1698baf3-f895-4c42-a1b1-e9ee3f20da36 | 16 |
| 2588077 | cabotegravir 600 MG in 3 ML Extended Release Injection | PSN | 1698baf3-f895-4c42-a1b1-e9ee3f20da36 | 16 |
| 2594982 | rilpivirine 600 MG in 2 ML Extended Release Injection | PSN | 1698baf3-f895-4c42-a1b1-e9ee3f20da36 | 16 |
| 2594980 | rilpivirine 900 MG in 3 ML Extended Release Injection | PSN | 1698baf3-f895-4c42-a1b1-e9ee3f20da36 | 16 |
| 2594978 | 2 ML cabotegravir 200 MG/ML Injection | SCD | 1698baf3-f895-4c42-a1b1-e9ee3f20da36 | 16 |
| 2594982 | 2 ML rilpivirine 300 MG/ML Injection | SCD | 1698baf3-f895-4c42-a1b1-e9ee3f20da36 | 16 |
| 2588077 | 3 ML cabotegravir 200 MG/ML Injection | SCD | 1698baf3-f895-4c42-a1b1-e9ee3f20da36 | 16 |
| 2594980 | 3 ML rilpivirine 300 MG/ML Injection | SCD | 1698baf3-f895-4c42-a1b1-e9ee3f20da36 | 16 |
| 2475418 | CABENUVA 400 MG / 600 MG Extended Release Kit | SY | 1698baf3-f895-4c42-a1b1-e9ee3f20da36 | 16 |
| 2475416 | CABENUVA 600 MG / 900 MG Extended Release Kit | SY | 1698baf3-f895-4c42-a1b1-e9ee3f20da36 | 16 |
| 2475417 | cabotegravir 400 MG / rilpivirine 600 MG Extended Release Kit | SY | 1698baf3-f895-4c42-a1b1-e9ee3f20da36 | 16 |
| 2594978 | cabotegravir 400 MG per 2 ML Injection | SY | 1698baf3-f895-4c42-a1b1-e9ee3f20da36 | 16 |
| 2475415 | cabotegravir 600 MG / rilpivirine 900 MG Extended Release Kit | SY | 1698baf3-f895-4c42-a1b1-e9ee3f20da36 | 16 |
| 2588077 | cabotegravir 600 MG per 3 ML Injection | SY | 1698baf3-f895-4c42-a1b1-e9ee3f20da36 | 16 |
| 2594982 | rilpivirine 600 MG per 2 ML Injection | SY | 1698baf3-f895-4c42-a1b1-e9ee3f20da36 | 16 |
| 2594980 | rilpivirine 900 MG per 3 ML Injection | SY | 1698baf3-f895-4c42-a1b1-e9ee3f20da36 | 16 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 49702-245-01 | 49702024501 | 2 mL in 1 VIAL | 2 ml | Historical | ||||
| 49702-249-02 | 49702024902 | 2 mL in 1 VIAL | 2 ml | Historical | ||||
| 49702-253-15 | 49702025315 | 1 KIT in 1 CARTON (49702-253-15) * 2 mL in 1 VIAL (49702-245-01) * 2 mL in 1 VIAL (49702-249-02) | 1 kit | 2021-01-21 | 0000-00-00 | No | No | Current |